Monopar Therapeutics MNPR 深 滬
等待開盤 09-20 09:30:00 美东时间
4.50
+0.560
+14.21%
華盛通- 最 高4.61
- 今 開3.90
- 成交量 24.78万股
- 最 低 3.90
- 昨 收 3.94
- 總市值 1584.18万
- 52周最高 8.65
- 市盈率 靜 --
- 換手率 7.04%
- 52周最低 1.3695
- 委 比 9.29%
- 總股本 352.04万
- 歷史最高 240.00
- 量 比 0.03
- 振 幅 18.02%
- 歷史最低 1.3695
- 每 手 1
- 風險率 0.97%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多伊芙美尔医疗盘中异动 下午盘大幅下跌6.33%
北京时间2024年09月13日02时21分，伊芙美尔医疗（ICCC.us）股票出现波动，股价大幅下挫6.33%。截至发稿，该股报3.55美元/股，成交量13....
09-13 02:21
Monopar stock rallies 60% on Phase 1 data for MNPR-101-Zr
Shares of Monopar Therapeutics (NASDAQ:MNPR) rallied 60% early Thursday after the company reported positive Phase 1 data for MNPR-101-Zr, a zirconium-89 imaging radioisotope conjugated to its monoclon...
09-12 23:05
Why Monopar Therapeutics (MNPR) Stock Is Skyrocketing Today
Monopar Therapeutics shares are trading higher by 108% Thursday morning. The company announced early Phase 1 trial data confirming MNPR-101-Zr's tumor-targeting ability in humans.
09-12 21:18
Monopar regains compliance with Nasdaq minimum bid price rule
Monopar Therapeutics (NASDAQ:MNPR) on Tuesday said it has received notice from Nasdaq that it has regained compliance with the minimum bid price requirement under listing rules. Source: Press Release ...
08-28 04:16
快讯 | Monopar Therapeutics Inc：Jonestrading将目标价从2美元调整为9美元以反映1比5股票拆分。
Monopar Therapeutics Inc : Jonestrading Adjusts Target Price to $9 From $2 to R...
08-19 13:32
快讯 | monopar therapeutics - mnpr-101-zr在最后一个影像时间点没有报告任何严重不良反应，耐受性好。
Monopar Therapeutics- Mnpr-101-Zr Well-Tolerated With No Serious Adverse Reacti...
08-14 20:02
快讯 | Monopar Therapeutics公司：H.c.Wainwright将目标价从2美元上调至6美元
Monopar Therapeutics Inc. : H.c. Wainwright Raises Target Price to $6 From $2
08-12 18:04
Monopar Therapeutics to implement 1-for-5 reverse stock split
Monopar Therapeutics (NASDAQ:MNPR) said it will effect a 1-for-5 reverse stock split of its outstanding shares of common stock. The company said that the reverse stock split is an effort to regain com...
08-09 20:29
Monopar Therapeutics Announces 1-For-5 Reverse Stock Split, Effective Monday August 12, 2024
Monopar Therapeutics Inc. (NASDAQ:MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients, today announced that it will effect a 1-for-5 reverse stock split of its
08-09 20:03
Monopar Therapeutics Begins Pioneering MNPR-101-Zr Trial
The latest announcement is out from Monopar Therapeutics Inc (MNPR). Monopar Th...
07-10 04:27
